Literature DB >> 9620683

SEK1/MKK4 is required for maintenance of a normal peripheral lymphoid compartment but not for lymphocyte development.

W Swat1, K Fujikawa, S Ganiatsas, D Yang, R J Xavier, N L Harris, L Davidson, R Ferrini, R J Davis, M A Labow, R A Flavell, L I Zon, F W Alt.   

Abstract

SAPK is a member of the group of evolutionary conserved stress-activated kinases that mediate control of cellular death and proliferation. In lymphocytes, the SAPK pathway has been implicated in signaling from antigen, costimulatory, and death receptors; SEK1, which directly activates SAPK, is required for early embryonic development and has also been reported to be essential for normal lymphocyte development. In contrast to the latter findings, we have used RAG-2-deficient blastocyst complementation to show that SEK1-deficient embryonic stem cells support unimpaired T and B lymphocyte development. Moreover, mature SEK1-deficient lymphocytes are capable of SAPK activation. Surprisingly, however, aging SEK1-deficient chimeric mice frequently develop lymphadenopathy and polyclonal B and T cell expansions. Thus, SEK1 is not required for lymphocyte development, but is required for maintaining peripheral lymphoid homeostasis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9620683     DOI: 10.1016/s1074-7613(00)80567-1

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  18 in total

1.  The MKK7 gene encodes a group of c-Jun NH2-terminal kinase kinases.

Authors:  C Tournier; A J Whitmarsh; J Cavanagh; T Barrett; R J Davis
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

2.  Delayed cell cycle progression in selenoprotein W-depleted cells is regulated by a mitogen-activated protein kinase kinase 4-p38/c-Jun NH2-terminal kinase-p53 pathway.

Authors:  Wayne Chris Hawkes; Zeynep Alkan
Journal:  J Biol Chem       Date:  2012-06-22       Impact factor: 5.157

3.  Interaction of a mitogen-activated protein kinase signaling module with the neuronal protein JIP3.

Authors:  N Kelkar; S Gupta; M Dickens; R J Davis
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

4.  POSH Regulates CD4+ T Cell Differentiation and Survival.

Authors:  Cody A Cunningham; Leah N Cardwell; Yue Guan; Emma Teixeiro; Mark A Daniels
Journal:  J Immunol       Date:  2016-04-15       Impact factor: 5.422

5.  ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis.

Authors:  K Tobiume; A Matsuzawa; T Takahashi; H Nishitoh; K Morita ; K Takeda; O Minowa; K Miyazono; T Noda; H Ichijo
Journal:  EMBO Rep       Date:  2001-03       Impact factor: 8.807

6.  Requirement of the JIP1 scaffold protein for stress-induced JNK activation.

Authors:  A J Whitmarsh; C Y Kuan; N J Kennedy; N Kelkar; T F Haydar; J P Mordes; M Appel; A A Rossini; S N Jones; R A Flavell; P Rakic; R J Davis
Journal:  Genes Dev       Date:  2001-09-15       Impact factor: 11.361

7.  Mucosal Humoral Immune Response to SIVmac239∆nef Vaccination and Vaginal Challenge.

Authors:  Ming Zeng; Anthony J Smith; Liang Shang; Stephen W Wietgrefe; James E Voss; John V Carlis; Qingsheng Li; Michael Piatak; Jeffrey D Lifson; R Paul Johnson; Ashley T Haase
Journal:  J Immunol       Date:  2016-02-10       Impact factor: 5.422

Review 8.  Signaling by the JNK group of MAP kinases. c-jun N-terminal Kinase.

Authors:  C Dong; R J Davis; R A Flavell
Journal:  J Clin Immunol       Date:  2001-07       Impact factor: 8.317

9.  Disruption of Mekk2 in mice reveals an unexpected role for MEKK2 in modulating T-cell receptor signal transduction.

Authors:  Zijian Guo; Gavin Clydesdale; Jinke Cheng; Kihwan Kim; Lin Gan; David J McConkey; Stephen E Ullrich; Yuan Zhuang; Bing Su
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

10.  MicroRNA-92a negatively regulates Toll-like receptor (TLR)-triggered inflammatory response in macrophages by targeting MKK4 kinase.

Authors:  Lihua Lai; Yinjing Song; Yang Liu; Qingyun Chen; Quan Han; Weilin Chen; Ting Pan; Yuanyuan Zhang; Xuetao Cao; Qingqing Wang
Journal:  J Biol Chem       Date:  2013-01-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.